The assignment of costs in a cost-effectiveness analysis is a complex and d
isputed issue. The Panel on Cost-Effectiveness in Health and Medicine was c
onvened to discuss standards that could be applied across a range of areas
of cost-effectiveness. Additionally, the Panel had a mandate to resolve som
e controversial issues about the practice of cost-effectiveness that create
d difficulty in making comparisons across studies. The Panel proposed these
guidelines: (1) Do at least some of the analysis from a social perspective
; (2) Assign values to resources that reflect their opportunity costs; (3)
Avoid zero counting of resources: (4) Avoid double counting of resources; (
5) Make analyses only as exacting as necessary in a study. Difficulties in
data collection were discussed. Among other questions considered by the pan
el were how to assign a value to the patient's time and which productivity
costs to include in a cost-effcctiveness analysis. With tools and suggestio
ns from the Panel on Cost-Effectiveness in Health and Medicine, the cost an
alyst can report costs accurately and provide accurate comparisons of cost
performance across states, trial modalities, or diseases.